AWM Investment Company Inc. Grows Position in Aspen Aerogels, Inc. (NYSE:ASPN)

AWM Investment Company Inc. grew its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 2.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,208,686 shares of the construction company’s stock after buying an additional 34,115 shares during the period. Aspen Aerogels comprises approximately 1.7% of AWM Investment Company Inc.’s portfolio, making the stock its 24th biggest holding. AWM Investment Company Inc.’s holdings in Aspen Aerogels were worth $14,359,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in ASPN. Sandia Investment Management LP acquired a new stake in Aspen Aerogels in the fourth quarter valued at approximately $89,000. AlphaQuest LLC raised its stake in shares of Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after buying an additional 3,998 shares during the period. KLP Kapitalforvaltning AS purchased a new position in shares of Aspen Aerogels during the 4th quarter valued at approximately $164,000. Connors Investor Services Inc. acquired a new stake in Aspen Aerogels in the 4th quarter valued at $168,000. Finally, Journey Strategic Wealth LLC acquired a new stake in Aspen Aerogels in the 4th quarter valued at $178,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ASPN has been the subject of a number of research analyst reports. TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. Seaport Res Ptn cut shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. Roth Mkm reduced their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Barclays lowered their price objective on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a report on Wednesday, February 19th. Finally, Canaccord Genuity Group reduced their target price on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a report on Friday, February 14th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average price target of $19.11.

Aspen Aerogels Stock Performance

Shares of Aspen Aerogels stock opened at $6.34 on Wednesday. The business’s 50 day moving average price is $5.85 and its 200 day moving average price is $9.91. The company has a market cap of $520.55 million, a price-to-earnings ratio of 39.63 and a beta of 2.72. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $33.15.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.01. The business had revenue of $78.72 million for the quarter, compared to analyst estimates of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The company’s quarterly revenue was down 16.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.02) EPS. On average, research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Insider Buying and Selling

In other Aspen Aerogels news, CEO Donald R. Young bought 20,000 shares of the business’s stock in a transaction on Monday, May 12th. The stock was bought at an average price of $5.35 per share, with a total value of $107,000.00. Following the completion of the purchase, the chief executive officer now directly owns 550,856 shares in the company, valued at $2,947,079.60. The trade was a 3.77% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.30% of the stock is owned by company insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.